Stocks / NASDAQ / PDL BioPharma, Inc.

PDL BioPharma, Inc.

Our Opinion

PDL BioPharma is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their pharmaceutical products.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

‘In laboratory experiments conducted by PDL and others, antibodies have been shown to block the function of these adhesion molecules, and in animal models these anti-adhesion antibodies have been shown to be effective at reducing many types of inflammation.” (Page 30) Read the full document

Company Description

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. PDL BioPharma was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV. [Source: MarketWatch]

Company Website: